APA (7th ed.) Citation

Menzies, A. M., Pires da Silva, I., Trojaniello, C., Vieu, E., Amaria, R. N., Zimmer, L., . . . Long, G. V. (2022). CTLA-4 Blockade Resistance after Relatlimab and Nivolumab. The New England journal of medicine, 386(17), 1668-1669. https://doi.org/10.1056/NEJMc2119768

Chicago Style (17th ed.) Citation

Menzies, Alexander M., et al. "CTLA-4 Blockade Resistance After Relatlimab and Nivolumab." The New England Journal of Medicine 386, no. 17 (2022): 1668-1669. https://doi.org/10.1056/NEJMc2119768.

MLA (9th ed.) Citation

Menzies, Alexander M., et al. "CTLA-4 Blockade Resistance After Relatlimab and Nivolumab." The New England Journal of Medicine, vol. 386, no. 17, 2022, pp. 1668-1669, https://doi.org/10.1056/NEJMc2119768.